New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis

Brain Pathology

Volumn 26, Issue 2, 2016, Pages 266-275

  Sabatelli, Mario ^a   Marangi, Giuseppe ^b   Conte, Amelia ^a   Tasca, Giorgio ^c   Zollino, Marcella ^b   Lattante, Serena ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

amyotrophic lateral sclerosis; distal myopathy; fronto temporal dementia; inclusion body myopathy; mitochondrial diseases

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DISTAL MYOPATHY; ELECTROMYOGRAM; EXOME; FRONTOTEMPORAL DEMENTIA; GENE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HUMAN; LOSS OF FUNCTION MUTATION; MATR3 GENE; MICROTUBULE; MISSENSE MUTATION; MOTOR UNIT POTENTIAL; NEUROLOGIC DISEASE; PATHOGENESIS; PHENOTYPE; PRESENILE DEMENTIA; SQSTM1 GENE; VCP GENE; ANIMAL; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; PHENOTYPE;

EID: 84961825328     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12354     Document Type: Conference Paper

References (126)

1. Abdelkarim S, Morgan S, Plagnol V, Lu CH, Adamson G, Howard R, et al, (2015) CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia. Brain 139:e9.
2. Abramzon Y, Johnson JO, Scholz SW, Taylor JP, Brunetti M, Calvo A, et al, (2012) Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33: 2231.
3. Ajroud-Driss S, Fecto F, Ajroud K, Lalani I, Calvo SE, Mootha VK, et al, (2015) Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics 16: 1-9.
4. Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, et al, (2014) A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 137: 2329-2345.
5. Benatar M, Wuu J, Fernandez C, Weihl CC, Katzen H, Steele J, et al, (2013) Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 80: 1874-1880.
6. Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, et al, (2001) Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci 191: 25-33.
7. Broccolini A, Mirabella M, (2015) Hereditary inclusion-body myopathies. Biochim Biophys Acta 1852: 644-650.
8. Broccolini A, Ricci E, Cassandrini D, Gliubizzi C, Bruno C, Tonoli E, et al, (2004) Novel GNE mutations in Italian families with autosomal recessive hereditary inclusion-body myopathy. Hum Mutat 23: 632.
9. Boutoleau-Bretonnière C, Camuzat A, Le Ber I, Bouya-Ahmed K, Guerreiro R, Deruet AL, et al, (2015) A phenotype of atypical apraxia of speech in a family carrying SQSTM1 mutation. J Alzheimers Dis 43: 625-630.
10. Bucelli RC, Arhzaouy K, Pestronk A, Pittman SK, Rojas L, Sue CM, et al, (2015) SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles. Neurology 85: 665-674.
11. Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, Hardiman O, (2011) Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12: 157-159.
12. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, et al, (2011) Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82: 623-627.
13. Cady J, Allred P, Bali T, Pestronk A, Goate A, Miller TM, et al, (2015) Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol 77: 100-113.
14. Chaussenot A, Le Ber I, Ait-El-Mkadem S, Camuzat A, de Septenville A, Bannwarth S, et al, (2014) Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol Aging 35: 2884.
15. Chen Y, Zheng ZZ, Chen X, Huang R, Yang Y, Yuan L, et al, (2014) SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis. Neurobiol Aging 35: 726.
16. Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, et al, (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135: 784-793.
17. Chiò A, Mora G, Sabatelli M, Caponnetto C, Traynor BJ, Johnson JO, et al, (2015) CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 36: 1767.
18. Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al, (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347: 1436-1441.
19. Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, Prelle A, et al, (1998) Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 43: 110-116.
20. Conte A, Lattante S, Luigetti M, Del Grande A, Romano A, Marcaccio A, et al, (2012) Classification of familial amyotrophic lateral sclerosis by family history: effects on frequency of genes mutation. J Neurol Neurosurg Psychiatry 83: 1201-1203.
21. Cozzolino M, Carrì MT, (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97: 54-66.
22. Cozzolino M, Rossi S, Mirra A, Carrì MT, (2015) Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis. Front Cell Neurosci 9: 31.
23. Crugnola V, Lamperti C, Lucchini V, Ronchi D, Peverelli L, Prelle A, et al, (2010) Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch Neurol 67: 849-854.
24. D'Agostino C, Nogalska A, Cacciottolo M, Engel WK, Askanas V, (2011) Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol 122: 627-636.
25. Dal Canto MC, Gurney ME, (1994) Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145: 1271-1279.
26. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al, (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256.
27. Di Mauro S, Schon EA, (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348: 2656-2668.
28. Di Mauro S, Schon EA, Carelli V, Hirano M, (2013) The clinical maze of mitochondrial neurology. Nat Rev Neurol 9: 429-444.
29. Dimachkie MM, Barohn RJ, (2014) Inclusion body myositis. Neurol Clin 32: 629-646.
30. Dobson-Stone C, Shaw AD, Hallupp M, Bartley L, McCann H, Brooks WS, et al, (2015) Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis? Brain 138: e385.
31. Dols-Icardo O, Nebot I, Gorostidi A, Ortega-Cubero S, Hernández I, Rojas-García R, et al, (2015) Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain. Brain 138:e400.
32. Eisen A, Kuwabara S, (2012) The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 83: 399-403.
33. Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al, (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68: 1440-1446.
34. Feit H, Silbergleit A, Schneider LB, Gutierrez JA, Fitoussi RP, Reyes C, et al, (1998) Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet 63: 1732-1742.
35. Fifita JA, Williams KL, McCann EP, O'Brien A, Bauer DC, Nicholson GA, Blair IP, (2015) Mutation analysis of MATR3 in Australian familial amyotrophic lateral sclerosis. Neurobiol Aging 36: 1602.
36. Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Müller K, et al, (2015) Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 18: 631-636.
37. Gang Q, Bettencourt C, Houlden H, Hanna MG, Machado PM, (2015) Genetic advances in sporadic inclusion body myositis. Curr Opin Rheumatol 27: 586-594.
38. González-Pérez P, Cirulli ET, Drory VE, Dabby R, Nisipeanu P, Carasso RL, et al, (2012) Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology 79: 2201-2208.
39. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP, (2009) Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology 72: 1948-1952.
40. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, et al, (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11: 54-65.
41. Heiman-Patterson TD, Argov Z, Chavin JM, Kalman B, Alder H, Di Mauro S, et al, (1997) Biochemical and genetic studies in a family with mitochondrial myopathy. Muscle Nerve 20: 1219-1224.
42. Hirano M, Angelini C, Montagna P, Hays AP, Tanji K, Mitsumoto H, et al, (2008) Amyotrophic lateral sclerosis with ragged-red fibers. Arch Neurol 65: 403-406.
43. Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, et al, (2013) Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 80: 458-463.
44. Hirano M, Nakamura Y, Saigoh K, Sakamoto H, Ueno S, Isono C, et al, (2015) VCP gene analyses in Japanese patients with sporadic amyotrophic lateral sclerosis identify a new mutation. Neurobiol Aging 36: 1604.
45. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T, et al, (2002) Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 11: 2735-2739.
46. Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al, (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68: 857-864.
47. Johnson JO, Glynn SM, Gibbs JR, Nalls MA, Sabatelli M, Restagno G, et al, (2014) Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain 137: e311.
48. Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, et al, (2014) Mutations in the matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci 17: 664-666.
49. Jokela M, Penttilä S, Huovinen S, Hackman P, Saukkonen AM, Toivanen J, Udd B, (2011) Late-onset lower motor neuronopathy: a new autosomal dominant disorder. Neurology 77: 334-340.
50. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al, (2013) Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495: 467-473.
51. Kimonis VE, Fulchiero E, Vesa J, Watts G, (2008) VCP disease associated withmyopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim Biophys Acta 1782: 744-748.
52. Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, et al, (2008) Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet A 146A: 745-757.
53. Koppers M, van Blitterswijk MM, Vlam L, Rowicka PA, van Vught PW, Groen EJ, et al, (2012) VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33: 837.
54. Kovacs GG, van der Zee J, Hort J, Kristoferitsch W, Leitha T, Höftberger R, et al, (2016) Clinicopathological description of two cases with SQSTM1 gene mutation associated with frontotemporal dementia. Neuropathology 36: 27-38.
55. Kumar KR, Needham M, Mina K, Davis M, Brewer J, Staples C, et al, (2010) Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings. Neuromuscul Disord 20: 330-334.
56. Kurzwelly D, Krüger S, Biskup S, Heneka MT, (2015) A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation. Brain 138: e376.
57. Kusters B, van Hoeve BJ, Schelhaas HJ, Ter Laak H, van Engelen BG, Lammens M, (2009) TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol 117: 209-211.
58. Kwok CT, Morris A, de Belleroche JS, (2014) Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB. Eur J Hum Genet 22: 492-496.
59. Kwok CT, Wang HY, Morris AG, Smith B, Shaw C, de Belleroche J, (2015) VCP mutations are not a major cause of familial amyotrophic lateral sclerosis in the UK. J Neurol Sci 349: 209-213.
60. Lattante S, Ciura S, Rouleau GA, Kabashi E, (2015) Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). Trends Genet 31: 263-273.
61. Laurin N, Brown JP, Morissette J, Raymond V, (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70: 1582-1588.
62. Le Ber I, Camuzat A, Guerreiro R, Bouya-Ahmed K, Bras J, Nicolas G, et al, (2013) SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol 70: 1403-1410.
63. Le Ber I, Van Bortel I, Nicolas G, Bouya-Ahmed K, Camuzat A, Wallon D, et al, (2014) hnRNPA2B1 and hnRNPA1 mutations are rare in patients with "multisystem proteinopathy" and frontotemporal lobar degeneration phenotypes. Neurobiol Aging 35: 934.
64. Leblond CS, Gan-Or Z, Spiegelman D, Laurent SB, Szuto A, Hodgkinson A, et al, (2016) Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 37: e17-e21.
65. Lin KP, Tsai PC, Liao YC, Chen WT, Tsai CP, Soong BW, Lee YC, (2015) Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol Aging 36: 2005.e1-4.
66. Malicdan MC, Noguchi S, Nishino I, (2007) Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Autophagy 3: 396-398.
67. Marroquin N, Stranz S, Müller K, Wieland T, Ruf WP, Brockmann SJ, et al, (2015) Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant. Brain 139:e8.
68. Millecamps S, Boillée S, Le Ber I, Seilhean D, Teyssou E, Giraudeau M, et al, (2012) Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J Med Genet 49: 258-263.
69. Millecamps S, De Septenville A, Teyssou E, Daniau M, Camuzat A, Albert M, et al, (2014) Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients. Neurobiol Aging 35: 2882.
70. Miller JW, Smith BN, Topp SD, Al-Chalabi A, Shaw CE, Vance C, (2012) Mutation analysis of VCP in British familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol Aging 33: 2721.
71. Müller K, Andersen PM, Hübers A, Marroquin N, Volk AE, Danzer KM, et al, (2014) Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain 137: e309.
72. Müller TJ, Kraya T, Stoltenburg-Didinger G, Hanisch F, Kornhuber M, Stoevesandt D, et al, (2014) Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann Neurol 76: 669-680.
73. Morel G, Rouzier C, Chaussenot A, Ait-El-Mkadem S, Bannwarth S, Genin EC, et al, (2015) CHCHD10 mutations are not a common cause of SMN1-negative type III-IV spinal motor atrophy. Ann Neurol 78: 831.
74. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al, (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
75. Olive M, Janue A, Moreno D, Gamez J, Torrejon-Escribano B, Ferrer I, (2009) TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol 68: 262-273.
76. Origone P, Verdiani S, Bandettini Di, Poggio M, Zuccarino R, Vignolo M, Caponnetto C, Mandich P, (2015) A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient. Amyotroph Lateral Scler Frontotemporal Degener 16: 530-531.
77. Palmio J, Sandell S, Suominen T, Penttilä S, Raheem O, Hackman P, et al, (2011) Distinct distal myopathy phenotype caused by VCP gene mutation in a Finnish family. Neuromuscul Disord 21: 551-555.
78. Palmio J, Evilä A, Bashir A, Norwood F, Viitaniemi K, Vihola A, et al, (2015) Re-evaluation of the phenotype caused by the common MATR3 p.Ser85Cys mutation in a new family. J Neurol Neurosurg Psychiatry. doi: 10.1136/jnnp-2014-309349.
79. Pasanen P, Myllykangas L, Pöyhönen M, Kiuru-Enari S, Tienari PJ, Laaksovirta H, et al, (2015) Intrafamilial clinical variability in individuals carrying the CHCHD10 mutation Gly66Val. Acta Neurol Scand. doi: 10.1111/ane.12470.
80. Pensato V, Tiloca C, Corrado L, Bertolin C, Sardone V, Del Bo R, et al, (2015) TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations. J Neurol 262: 1376-1378.
81. Penttilä S, Jokela M, Bouquin H, Saukkonen AM, Toivanen J, Udd B, (2015) Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. Ann Neurol 77: 163-172.
82. Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, et al, (2015) Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol 130: 77-92.
83. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al, (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83: 102-108.
84. Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, et al, (2012) C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 33: 2528.
85. Rea SL, Majcher V, Searle MS, Layfield R, (2014) SQSTM1 mutations - bridging Paget disease of bone and ALS/FTLD. Exp Cell Res 325: 27-37.
86. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al, (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268.
87. Ronchi D, Garone C, Bordoni A, Gutierrez Rios P, Calvo SE, Ripolone M, et al, (2012) Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 135: 3404-3415.
88. Ronchi D, Riboldi G, Del Bo R, Ticozzi N, Scarlato M, Galimberti D, et al, (2015) CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. Brain 138: e372.
89. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62.
90. Rubino E, Rainero I, Chiò A, Rogaeva E, Galimberti D, Fenoglio P, et al, (2012) SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79: 1556-1562.
91. Sabatelli M, Madia F, Conte A, Luigetti M, Zollino M, Mancuso I, et al, (2008) Natural history of young-adult amyotrophic lateral sclerosis. Neurology 71: 876-881.
92. Sabatelli M, Zollino M, Luigetti M, Grande AD, Lattante S, Marangi G, et al, (2011) Uncovering amyotrophic lateral sclerosis phenotypes: clinical features and long-term follow-up of upper motor neuron-dominant ALS. Amyotroph Lateral Scler 12: 278-282.
93. Sabatelli M, Conte A, Zollino M, (2013) Clinical and genetic heterogeneity of amyotrophic lateral sclerosis. Clin Genet 83: 408-416.
94. Salajegheh M, Pinkus JL, Taylor JP, Amato AA, Nazareno R, Baloh RH, Greenberg SA, (2009) Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40: 19-31.
95. Seelen M, Visser AE, Overste DJ, Kim HJ, Palud A, Wong TH, et al, (2014) No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy. Neurobiol Aging 35: 1956.
96. Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, et al, (2009) Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 84: 511-518.
97. Shimizu H, Toyoshima Y, Shiga A, Yokoseki A, Arakawa K, Sekine Y, et al, (2013) Sporadic ALS with compound heterozygous mutations in the SQSTM1 gene. Acta Neuropathol 126: 453-459.
98. Simón-Sánchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H, et al, (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135: 723-735.
99. Smith BN, Newhouse S, Shatunov A, Vance C, Topp S, Johnson L, et al, (2013) The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder. Eur J Hum Genet 21: 102-108.
100. Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp S, Kenna KP, et al, (2014) Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 84: 324-331.
101. Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, et al, (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123: 409-417.
102. Stojkovic T, Hammouda el H, Richard P, López de Munain A, Ruiz-Martinez J, Camaño P, et al, (2009) Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia. Neuromuscul Disord 19: 316-323.
103. Swinnen B, Robberecht W, (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10: 661-670.
104. Tan W, Pasinelli P, Trotti D, (2014) Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis. Biochim Biophys Acta 1842: 1295-1301.
105. Tasca G, Monforte M, De Fino C, Kley RA, Ricci E, Mirabella M, (2015) Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve Mar 52: 956-962.
106. Taylor JP, (2015) Multisystem proteinopathy: intersecting genetics in muscle, bone, and brain degeneration. Neurology 85: 658-660.
107. Tiloca C, Ratti A, Pensato V, Castucci A, Sorarù G, Del Bo R, et al, (2012) Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis. Neurobiol Aging 33: 630.
108. Teyssou E, Takeda T, Lebon V, Boillée S, Doukouré B, Bataillon G, et al, (2013) Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 125: 511-522.
109. Tucker WS Jr, Hubbard WH, Stryker TD, Morgan SW, Evans OB, Freemon FR, Theil GB, (1982) A new familial disorder of combined lower motor neuron degeneration and skeletal disorganization. Trans Assoc Am Physicians 95: 126-134.
110. Udd B, (2012) Distal myopathies-new genetic entities expand diagnostic challenge. Neuromuscul Disord 22: 5-12.
111. van der Zee J, Pirici D, Van Langenhove T, Engelborghs S, Vandenberghe R, Hoffmann M, et al, (2009) Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 73: 626-632.
112. van der Zee J, Van Langenhove T, Kovacs GG, Dillen L, Deschamps W, Engelborghs S, et al, (2014) Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol 128: 397-410.
113. van Rheenen W, Diekstra FP, van den Berg LH, Veldink JH, (2014) Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis? Brain 137: e313.
114. Viassolo V, Previtali SC, Schiatti E, Magnani G, Minetti C, Zara F, et al, (2008) Inclusion body myopathy, Paget's disease of the bone and frontotemporal dementia: recurrence of the VCP R155H mutation in an Italian family and implications for genetic counselling. Clin Genet 74: 54-60.
115. Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al, (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nature Genet 36: 377-381.
116. Weihl CC, Dalal S, Pestronk A, Hanson PI, (2006) Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum Mol Genet 15: 189-199.
117. Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, et al, (2008) TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79: 1186-1189.
118. Weihl CC, Pestronk A, Kimonis VE, (2009) Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul Disord 19: 308-315.
119. Weihl CC, Baloh RH, Lee Y, Chou TF, Pittman SK, Lopate G, et al, (2015) Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis. Neuromuscul Disord 25: 289-296.
120. Williams KL, Solski JA, Nicholson GA, Blair IP, (2012) Mutation analysis of VCP in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 33: 1488.
121. Williams KL, McCann EP, Fifita JA, Zhang K, Duncan EL, Leo PJ, et al, (2015) Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin. Neurobiol Aging 36: 3334.
122. Yamashita S, Mori A, Nishida Y, Kurisaki R, Tawara N, Nishikami T, et al, (2015) Clinicopathological features of the first Asian family having vocal cord and pharyngeal weakness with distal myopathy due to a MATR3 mutation. Neuropathol Appl Neurobiol 41: 391-398.
123. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al, (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116.
124. Wong CH, Topp S, Gkazi AS, Troakes C, Miller JW, de Majo M, et al, (2015) The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Neurobiol Aging 36: 2908.
125. Zhang M, Xi Z, Zinman L, Bruni AC, Maletta RG, Curcio SA, et al, (2015) Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain 138: e380.
126. Zou ZY, Liu MS, Li XG, Cui LY, (2013) Screening of VCP mutations in Chinese amyotrophic lateral sclerosis patients. Neurobiol Aging 34: 1519.